<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ920204-0015</DOCNO><DOCID>920204-0015.</DOCID><HL>   Business Brief:   Dow Corning Net   Fell 35% in Period   On Special Charge</HL><DATE>02/04/92</DATE><SO>WALL STREET JOURNAL (J), PAGE B6</SO><CO>   DOW GLW</CO><MS>BASIC MATERIALS (BSC)TECHNOLOGY (TEC)</MS><IN>COMMODITY CHEMICALS (CHC)CHEMICALS, PLASTICS (CHM)DIVERSIFIED TECHNOLOGY (DTC)EARNINGS (ERN)</IN><NS>EARNINGS (ERN)</NS><RE>MICHIGAN (MI)NORTH AMERICA (NME)NEW YORK (NY)UNITED STATES (US)</RE><LP>   MIDLAND, Mich. -- Dow Corning Corp., taking a promised $25million charge to cover various costs involving itscontroversial breast implants, said net income in the fourthquarter slid 35% despite a 5.1% sales rise.   Net income fell to $28.9 million at the company, a jointventure of Dow Chemical Co. and Corning Inc., down from $44.7million a year earlier. Sales climbed to $472.3 million, upfrom the year-earlier $449.2 million.</LP><TEXT>   Dow Corning is a major maker of silicone-gel breastimplants, whose safety has been questioned by the Food andDrug Administration, which is investigating the devices. Thecompany assessed the charge against fourth-quarter earningsto cover any legal liability arising from the implants, thecosts of unused inventory and of trying to prove theimplants' safety.   Last month, when the company said it would take thecharge, it also closed the production lines that make theimplants. Breast-implant sales represent only about 1% of DowCorning's total sales and the business has been unprofitablefor &quot;a number of years,&quot; the company said.   For all of 1991, Dow Corning earned $152.9 million, down10.6% from the year-earlier $171.1 million, on a 7% salesgain to $1.85 billion.</TEXT></DOC>